IperionX (ASX:IPX) Output Jumps 5x, Is the Buy Case Finally Real?

We know a lot of Australian investors are either holding IPX or have it on their radar as a potential portfolio candidate, so we wanted to put together a focused refresher on the stock rather than rehash the marketing content that dominated today’s investor presentation.

What caught our attention was the first real-time production data we have seen since our H1 earnings analysis back in March. That alone made today’s announcement worth sitting through.

IperionX Limited (ASX:IPX) has moved its Virginia titanium manufacturing campus to 24/7 continuous production, and monthly HAMR powder output reached approximately 4.2 metric tons in March 2026, equivalent to around 50 tpa annualised. With the US defence budget expected to reach US$1.4 trillion in FY27, increasingly tilting toward domestic manufacturing, the setup for IPX is getting harder to ignore. We wanted to map out what this stock could realistically look like in an upside scenario, particularly as the US doubles down on reshoring its industrial base and titanium sits right at the centre of that conversation.

The Setup Has Never Been Better, But Execution Is Everything

The powder output chart tracks monthly deoxygenation performance, which is essentially the HAMR process stripping excess oxygen from titanium scrap to deliver a higher purity output. HAMR, or Hydrogen Assisted Metallothermic Reduction, is IPX’s proprietary method for converting recycled titanium into higher-grade powder. Higher purity means IPX can command a higher price point for the end product, though this remains theoretical for now.

What the chart actually shows is a production ramp worth paying attention to. Monthly output climbed from roughly 0.8 metric tons in the October to December 2025 average, to 1.3mt in January, 2.7mt in February, and 4.3mt in March 2026. That is a 5x scale-up over three months, and for the first time, investors have a real metric to assess whether this technology can actually scale.

If IPX holds anywhere near this pace, meaningful shipment volumes could arrive well ahead of the 1,400 tpa expansion initiative. That changes the near-term narrative considerably.

Context matters here though. This is still early-stage output, and the numbers remain well below the 200 tpa nameplate capacity. At full utilisation, that facility would produce around 16.7mt per month. At March’s rate of 4.3mt, IPX is running at roughly 26% utilisation. Encouraging progress, but there is a long runway still ahead.

The Cost Curve Improvement Is the Long Game

Arguably the most important part of the scale-up story is what it does to the cost curve. As output climbs, the economics are already starting to improve, and that tells us economies of scale are beginning to come through even at these relatively modest volumes.

The numbers lay it out clearly. At 200 tpa, unit costs sit around US$55 per kg. Management’s target at 1,400 tpa is US$29 per kg, a 47% cost reduction driven by scale alone. If IPX reaches that milestone by mid-2027, the company could be selling at prices competitive with imported material while still generating meaningful margins. That is a structurally different business to what exists today.

The GenX platform sits behind that cost ambition. GenX is the next-generation continuous version of the HAMR process, redesigned to run without the stops inherent in batch production. Continuous production almost always costs less per kilogram, because the plant uses less energy and delivers more predictable output. GenX has not yet had commercial-scale data disclosed, so it remains the critical watch item for the remainder of CY2026.

The Investors’ Takeaway for IperionX

For this piece we are deliberately focused on the unit economics and the upside potential of IPX, because the risk side of the ledger is something we covered in depth in our last note. The short version is IPX burns significant cash, but with US$48.2 million on hand at March 31, 2026 and US$42.1 million in remaining obligated reimbursable US government funding, that burn is being materially subsidised in a way that changes the risk profile considerably.

With production sitting at roughly 26% utilisation, the next milestone investors need to see is a continued ramp toward the 200 tpa nameplate capacity. Running the numbers at 1,400 tpa, using the blended selling price of around US$130 per kg from the presentation and a conservative unit production cost assumption of US$34 per kg, the market cap potential starts to look materially different from where IPX trades today. On that basis, we could see the stock supporting a market cap somewhere in the A$2.6 billion to A$3.4 billion range.

The flip side is equally important to flag. If the ramp faces delays or the unit economics disappoint, the downside could be significant. This is a story with real asymmetry in both directions, and that is something investors need to sit with before sizing a position. More coverage of ASX-listed titanium and advanced materials names is available at stocksdownunder.